| Larry Alphs, M.D., Ph.D. |
| Therapeutic Area Leader in Psychiatry, Medical and Scientific Affairs, Ortho-McNeil Janssen Scientific Affairs |
| Ravi Anand , M.D. |
| Principal Consultant, Anand Pharma Consulting |
| Ross Baldessarini, M.D. |
| Director: Neuropharmacology Laboratory, Bipolar & Psychotic Disorders Program, International Consortium for Bipolar Disorders Research, and Psychopharmacology Program and Consultation Service, McLean Hospital |
| Ralph Benedict, Ph.D. |
| Professor of Neurology, SUNY Buffalo |
| Charles Bowden, M.D. |
| Nancy U. Karren Professor in the Department of Psychiatry, University of Texas Health Science Center at San Antonio |
| Karl Broich , M.D. |
| Director, Professor, Manager, Federal Institute for Drugs and Medical Devices (BfArM) |
| Ross Bullock, M.D., Ph.D., F.R.C.S. |
| Clinical Director, Neurotrauma Program, Department of Neurological Surgery, University of Miami Leonard M. Miller School of Medicine |
| Katherine Burdick, Ph.D. |
| Assistant Professor of Psychiatry, Albert Einstein College of Medicine |
| Joseph Calabrese, M.D. |
| Director of the Mood Disorders Program, University Hospitals of Cleveland |
| Kathleen Clarence-Smith, M.D., Ph.D. |
| Senior Vice President, Stanford Group Company |
| Lori Davis, M.D. |
| Associate Professor of Psychiatry, School of Medicine, University of Alabama at Birmingham |
| Alan Faden, M.D. |
| Professor, Department of Neuroscience, Georgetown University Medical Center |
| Reuven Ferziger, M.D. |
| Scientific Affairs, Ortho-McNeil Janssen Scientific Affairs, LLC |
| Jonathan Fleming |
| Managing General Partner, Oxford Bioscience Partners |
| Richard G. Frank, Ph.D. |
| Harvard School of Medicine, Dept of Health Policy |
| Howard Goldman, M.D., Ph.D. |
| Professor of Psychiatry at the University of Maryland School of Medicine |
| Michael Green, Ph.D. |
| Professor, Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA |
| Thomas Insel, M.D. |
| Director, NIMH |
| Michael Jaffee, M.D. |
| National Director, Defense and Veterans Brain Injury Center |
| Amir Kalali , M.D., MRCPsych |
| Vice President, Medical and Scientific Services, Quintiles Global CRO |
| Russell Katz, M.D. |
| FDA, Director; Division of Neurology Products; Office of Drug Evaluation I; Office of New Drugs; CDER |
| Richard Keefe, Ph.D. |
| Professor, Departments of Psychiatry and Behavioral Sciences and Psychology, Duke University Medical Center |
| Thomas Laughren , M.D. |
| Division Director, Division of Psychiatry Products, Center for Drug Evaluation and Research, FDA |
| Andrew C Leon, Ph.D. |
| Professor of Biostatistics in Psychiatry, Weill Cornell Medical College |
| David Loring, Ph.D. |
| Rene Aerts/Virginia J. Cosper Professor, Departments of Neurology and Clinical Health Psychology, University of Florida |
| Mark Lovell, Ph.D. |
| Associate Professor, Sanders-Brown Center on Aging |
| Thomas Macek, Pharm.D., Ph.D. |
| Director, Clinical Science, CNS Products, Takeda Global Research & Development Center, Inc. |
| Ron Manderscheid, Ph.D. |
| Director of Mental Health and Substance Use Programs, Global Health Sector, SRA International |
| Thomas Neylan, M.D. |
| Medical Director, PTSD Research Program, San Francisco VA Medical Center. |
| Stephen Rao, Ph.D. |
| Director, Cleveland Clinic Schey Center |
| Karen Schwab, Ph.D. |
| Chief of Epidemiology and Statistics, Defense and Veterans Brain Injury Center, Uniformed Services University of the Health Sciences |
| Doug Smith, M.D. |
| Director, Penn Center for Brain Injury and Repair |
| Donald Steinwachs, Ph.D. |
| Professor and Director, Health Services Research and Development Center, Department of Health Policy and Management, Bloomberg School of Public Health Johns Hopkins University |
| Alina Suris, Ph.D. |
| Director, Womens Stress Disorder and Military Sexual Trauma Team, Veterans Affairs North Texas Health Care System |
| Mauricio Tohen, M.D., D.Ph. |
| Distinguished Lilly Scholar for Neurosciences, Lilly Research Laboratories |
| Gretchen Tucker |
| Janet Vergis |
| President, Janssen and Ortho-McNeil Neurologics |
| Eduard Vieta, M.D. |
| Professor of Psychiatry and Director of the Bipolar Disorders Program of the Hospital Clinic, University of Barcelona |
| Philip Wang , M.D., Dr.P.H. |
| Director, Division of Services and Intervention Research, National Institute of Mental Health |
| Click here for Complete Biographical Profiles |